Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2025-12-29 @ 6:51 PM
Study NCT ID:
NCT01582061
Status:
COMPLETED
Last Update Posted:
2018-06-19
First Post:
2012-04-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-12
First Submit QC Date:
None
Study First Post Date:
2012-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-26
Results First Submit QC Date:
None
Results First Post Date:
2018-06-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-24
Last Update Post Date:
2018-06-19
Last Update Post Date Type:
ACTUAL